Salvia BioElectronics Overview

  • Founded
  • 2017
Founded
  • Status
  • Private
  • Employees
  • 17
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $24.9M
Latest Deal Amount
  • Investors
  • 9

Salvia BioElectronics General Information

Description

Developer of bioelectronic alternatives intended to assist in the treatment of chronic neurological disease. The company's offerings include smart devices that use mild electrical impulses to influence nerve activity that restores health for people suffering from chronic migraine, enabling patients to access to a neurostimulation alternative for drug-refractory migraine.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • High Tech Campus 41
  • 5656 AE Eindhoven
  • Netherlands

Salvia BioElectronics Timeline

201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Salvia BioElectronics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) 22-Sep-2020 $24.9M 000.00 Completed Startup
3. Seed Round 31-Jan-2019 00.000 00.000 Completed Startup
2. Grant 01-Jun-2018 $748K $1.55M Completed Startup
1. Seed Round 22-May-2018 $1.55M $1.55M Completed Startup
To view Salvia BioElectronics’s complete valuation and funding history, request access »

Salvia BioElectronics Executive Team (4)

Name Title Board Seat Contact Info
Daniël Schobben Ph.D Co-Founder, Chief Operating Officer & Executive, Business Development
Wim Pollet MD Co-Founder & Chief Medical Officer
Michel Decré Ph.D Co-Founder
Hubert Martens Ph.D Co-Founder & Chief Executive Officer
To view Salvia BioElectronics’s complete executive team members history, request access »

Salvia BioElectronics Board Members (6)

Name Representing Role Since
Diana Saraceni Panakes Partners Board Member 000 0000
Florian Ludwig Ph.D Thuja Capital Management Board Observer 000 0000
Jeroen Siemes Brabantse Ontwikkelings Maatschappij Board Observer 000 0000
Roel Bulthuis Inkef Capital Board Member 000 0000
Sascha Alilovic SHS Gesellschaft fur Beteiligungsmanagement Board Member 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Salvia BioElectronics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Salvia BioElectronics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Dolby Family Ventures Venture Capital Minority 000 0000 000000 0
Inkef Capital Venture Capital Minority 000 0000 000000 0
Panakes Partners Venture Capital Minority 000 0000 000000 0
SHS Gesellschaft fur Beteiligungsmanagement Growth/Expansion Minority 000 0000 000000 0
Brabant Startup Fund Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »